Man charged over unlicensed cancer drugs
Print Edition
A MAN alleged to have sold unlicensed anti-cancer drugs has been charged with conducting an illegal business, Minhang District Prosecutors’ Office said yesterday.
Made in India, the brands involved included Bayer’s Nexavar, Roche’s Tarceva, AstraZeneca’s Iressa and Norvartis’ Glivec.
The Indian drugs cost a fraction of the price of certified products.
Prosecutors said the accused, a 32-year-old surnamed Yu, was running an illegal business and selling unlicensed drugs.
According to prosecutors, Yu became involved in the trade after his father was diagnosed with lung cancer.
Yu searched for information online and bought six bottles of Iressa for 7,000 yuan (US$1,123) to give to his father.
However, Yu was told that his father was to undergo surgery and would therefore no longer need the medication.
Yu offered the drugs for sale online and quickly sold them.
Afterward, he discovered that Indian anti-cancer drugs were much cheaper and bought supplies from Indian sources to sell at his online store, claim prosecutors.
Between September 2013 and March 2014 Yu made 72,745 yuan (US$11,639) from his business.
Under Chinese law, any unlicensed drugs that are traded in the country are regarded as being fake products.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
